By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Versartis, Inc.  

4200 Bohannon Drive
Suite 250
Menlo Park  California  94025  U.S.A.
Phone: 650-963-8588 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Versartis (VSAR) Presents 3-Year Somavaratan Safety And Efficacy Data And Pediatric Program Baseline Demographics At The 19th European Congress Of Endocrinology 5/22/2017 9:52:46 AM
Versartis (VSAR) Reports First Quarter 2017 Financial Results 4/28/2017 10:43:20 AM
Versartis (VSAR) Appoints Jay Stout, Ph.D., As Senior Vice President, Technical Operations 4/25/2017 9:50:40 AM
Versartis (VSAR) Announces Three Year Somavaratan Data At ENDO 2017 Showing Safety And Efficacy In Line With Historical U.S. Daily rhGH Data In Pediatric GHD 4/3/2017 9:33:28 AM
Versartis (VSAR) Reports New Data On Long-Acting Somavaratan In Growth Hormone Deficiency At ENDO 2017 4/3/2017 7:42:56 AM
Versartis (VSAR) Presents Efficacy, Safety, Metabolic And Adherence Data For Somavaratan In Oral Session At The International Congress Of Endocrinology 9/6/2016 8:03:55 AM
Bay Area's Versartis (VSAR) Strikes $165 Million Growth Hormone Deal With Teijin Limited 8/10/2016 8:42:51 AM
Versartis, Inc. (VSAR) Presents Confirmatory 18-Month Adherence Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ENDO Annual Meeting 4/1/2016 8:04:15 AM
Versartis, Inc. (VSAR) To Present At The Cowen and Company 36th Annual Health Care Conference 3/2/2016 8:18:23 AM
Versartis, Inc. (VSAR) Reports Confirmatory Top-Line Two-Year Data From Ongoing Extension Study Of Somavaratan In GHD Children 2/2/2016 7:52:28 AM
123456789
//-->